Family history of premature CHD and risk factor control in patients with a recent ACS

Daniel Yu-Hung Jeng1,2, Haeri Min3, Simone Marschner3

  • 1Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. danieljeng57@gmail.com.

PubMed

Insights

Knowing about a family history of premature heart disease (CHD) did not significantly improve risk factor control in patients after an acute coronary syndrome (ACS). Novel strategies are needed for better secondary prevention in this high-risk group.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • A family history of premature coronary heart disease (CHD) is a significant risk factor for cardiac events.
  • Individuals with a family history may be motivated to adopt healthier behaviors for secondary prevention after experiencing an acute coronary syndrome (ACS).

Purpose of the Study:

  • To investigate if a self-reported family history of premature CHD influences risk factor and health behavior control at 12 months post-ACS.
  • To assess the association between family history knowledge and outcomes like blood pressure control, LDL cholesterol, BMI, exercise, and smoking status.

Main Methods:

  • Analysis of data from the TEXTMEDS study.
  • Inclusion of 1423 participants (556 with family history, 867 without).
  • Evaluation of risk factor control (blood pressure, LDL cholesterol, BMI) and health behaviors (exercise, smoking) at 12 months post-ACS.

Main Results:

  • No statistically significant evidence was found indicating that patients aware of their family history achieved better control of risk factors.
  • The presence of a family history of premature CHD did not correlate with improved health behaviors at 12 months post-ACS.

Conclusions:

  • Knowledge of a family history of premature CHD alone is insufficient to drive improved secondary prevention outcomes post-ACS.
  • There is a critical need for developing and implementing novel strategies to enhance risk factor control and secondary prevention in patients with a family history of CHD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...